These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 17543421)

  • 1. Metabolic correlates of clinical heterogeneity in questionable Alzheimer's disease.
    Salmon E; Lekeu F; Garraux G; Guillaume B; Magis D; Luxen A; Moonen G; Collette F
    Neurobiol Aging; 2008 Dec; 29(12):1823-9. PubMed ID: 17543421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
    Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18FDG PET in vascular dementia: differentiation from Alzheimer's disease using voxel-based multivariate analysis.
    Kerrouche N; Herholz K; Mielke R; Holthoff V; Baron JC
    J Cereb Blood Flow Metab; 2006 Sep; 26(9):1213-21. PubMed ID: 16525414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled memory processes in questionable Alzheimer's disease: a view from neuroimaging research.
    Bastin C; Kerrouche N; Lekeu F; Adam S; Guillaume B; Lemaire C; Aerts J; d'Ydewalle G; Collette F; Salmon E
    J Alzheimers Dis; 2010; 20(2):547-60. PubMed ID: 20164554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the multivariate nature of brain metabolic impairment in Alzheimer's disease.
    Salmon E; Kerrouche N; Perani D; Lekeu F; Holthoff V; Beuthien-Baumann B; Sorbi S; Lemaire C; Collette F; Herholz K
    Neurobiol Aging; 2009 Feb; 30(2):186-97. PubMed ID: 17651869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.
    Hunt A; Schönknecht P; Henze M; Seidl U; Haberkorn U; Schröder J
    Psychiatry Res; 2007 Jul; 155(2):147-54. PubMed ID: 17524628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
    J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain metabolism in the cerebellum and visual cortex correlates with neuropsychological testing in patients with Alzheimer's disease.
    Newberg A; Cotter A; Udeshi M; Brinkman F; Glosser G; Alavi A; Clark C
    Nucl Med Commun; 2003 Jul; 24(7):785-90. PubMed ID: 12813197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.
    Gilman S; Koeppe RA; Little R; An H; Junck L; Giordani B; Persad C; Heumann M; Wernette K
    Exp Neurol; 2005 Feb; 191 Suppl 1():S95-S103. PubMed ID: 15629765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
    Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical Metabolic and Cognitive Correlates of Disorientation in Alzheimer's Disease.
    Weissberger GH; Melrose RJ; Fanale CM; Veliz JV; Sultzer DL
    J Alzheimers Dis; 2017; 60(2):707-719. PubMed ID: 28869474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.
    Minoshima S; Giordani B; Berent S; Frey KA; Foster NL; Kuhl DE
    Ann Neurol; 1997 Jul; 42(1):85-94. PubMed ID: 9225689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of cortical activity and memory performance in Alzheimer's disease.
    Schröder J; Buchsbaum MS; Shihabuddin L; Tang C; Wei TC; Spiegel-Cohen J; Hazlett EA; Abel L; Luu-Hsia C; Ciaravolo TM; Marin D; Davis KL
    Biol Psychiatry; 2001 Mar; 49(5):426-36. PubMed ID: 11274654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered cerebral energy metabolism in Alzheimer's disease: a PET study.
    Fukuyama H; Ogawa M; Yamauchi H; Yamaguchi S; Kimura J; Yonekura Y; Konishi J
    J Nucl Med; 1994 Jan; 35(1):1-6. PubMed ID: 8271029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks.
    Varrone A; Pappatà S; Caracò C; Soricelli A; Milan G; Quarantelli M; Alfano B; Postiglione A; Salvatore M
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1447-54. PubMed ID: 12397463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of regional brain volume and glucose metabolism between patients with mild dementia with lewy bodies and those with mild Alzheimer's disease.
    Ishii K; Soma T; Kono AK; Sofue K; Miyamoto N; Yoshikawa T; Mori E; Murase K
    J Nucl Med; 2007 May; 48(5):704-11. PubMed ID: 17475957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-center study on Alzheimer's disease using FDG PET: group and individual analyses.
    Yuan X; Shan B; Ma Y; Tian J; Jiang K; Cao Q; Wang R
    J Alzheimers Dis; 2010; 19(3):927-35. PubMed ID: 20157248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfusion SPECT and FDG-PET.
    Herholz K
    Int Psychogeriatr; 2011 Sep; 23 Suppl 2():S25-31. PubMed ID: 21729421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.